Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD.
Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.
Mol Cancer Ther. 2003 Jul;2(7):617-22.
PMID: 12883034 [PubMed - indexed for MEDLINE]
Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas.
Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M.
Cancer Res. 2004 Aug 15;64(16):5617-23.
PMID: 15313899
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents.
Pisanti S, Malfitano AM, Grimaldi C, Santoro A, Gazzerro P, Laezza C, Bifulco M.
Best Pract Res Clin Endocrinol Metab. 2009 Feb;23(1):117-31.
PMID: 19285265
doi:10.1016/j.beem.2009.02.001
Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma.
Yoshiji H, Noguchi R, Toyohara M, Ikenaka Y, Kitade M, Kaji K, Yamazaki M, Yamao J, Mitoro A, Sawai M, Yoshida M, Fujimoto M, Tsujimoto T, Kawaratani H, Uemura M, Fukui H.
J Hepatol. 2009 Aug;51(2):315-21. Epub 2009 May 15.
PMID: 19501932
CONCLUSIONS: The combination treatment of VK and ACE-I may suppress the cumulative recurrence of HCC after the curative therapy, at least partly through suppression of the VEGF-mediated neovascularization.
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
Casanova ML, Blázquez C, Martínez-Palacio J, Villanueva C, Fernández-Aceñero MJ, Huffman JW, Jorcano JL, Guzmán M.
J Clin Invest. 2003 Jan;111(1):43-50.
PMID: 12511587
doi:10.1172/JCI16116